Drug Industry , Health Equity , Pharmaceutical Preparations , Research Support as Topic , Humans , Drug Industry/economics , International Cooperation , Pandemics , Research Support as Topic/economics , Research Support as Topic/organization & administration , Research Support as Topic/trends , Health Equity/economics , Health Equity/trends , Pharmaceutical Preparations/economics , Pharmaceutical Preparations/supply & distribution
Clinical Trials as Topic , Exercise Therapy , National Institutes of Health (U.S.) , Post-Acute COVID-19 Syndrome , Research Support as Topic , Humans , National Institutes of Health (U.S.)/economics , National Institutes of Health (U.S.)/organization & administration , Post-Acute COVID-19 Syndrome/therapy , Research Support as Topic/methods , Research Support as Topic/organization & administration , United States , Exercise Therapy/adverse effects
BACKGROUND: Musculoskeletal (MSK) injuries are one of the leading causes of disability worldwide. Despite improvements in trauma-related morbidity and mortality in high-income countries over recent years, outcomes following MSK injuries in low- and middle-income countries, such as South Africa (SA), have not. Despite governmental recognition that this is required, funding and research into this significant health burden are limited within SA. This study aims to identify research priorities within MSK trauma care using a consensus-based approach amongst MSK healthcare practitioners within SA. METHOD: Members from the Orthopaedic Research Collaboration in Africa (ORCA), based in SA, collaborated using a two round modified Delphi technique to form a consensus on research priorities within orthopaedic trauma care. Members involved in the process were orthopaedic healthcare practitioners within SA. RESULTS: Participants from the ORCA network, working within SA, scored research priorities across two Delphi rounds from low to high priority. We have published the overall top 10 research priorities for this Delphi process. Questions were focused on two broad groups-clinical effectiveness in trauma care and general trauma public health care. Both groups were represented by the top two priorities, with the highest ranked question regarding the overall impact of trauma in SA and the second regarding the clinical treatment of open fractures. CONCLUSION: This study has defined research priorities within orthopaedic trauma in South Africa. Our vision is that by establishing consensus on these research priorities, policy and research funding will be directed into these areas. This should ultimately improve musculoskeletal trauma care across South Africa and its significant health and socioeconomic impacts.
Musculoskeletal System , Orthopedics , Research Support as Topic , Research , Humans , Consensus , Delivery of Health Care , Orthopedics/organization & administration , Orthopedics/standards , Research/economics , Research/organization & administration , South Africa , Biomedical Research/economics , Biomedical Research/organization & administration , Musculoskeletal System/injuries , Wounds and Injuries , Delphi Technique , Fractures, Open , Research Support as Topic/economics , Research Support as Topic/organization & administration
COVID-19 , National Institutes of Health (U.S.) , Research Support as Topic , Child , Humans , COVID-19/complications , COVID-19/economics , Financial Management , National Institutes of Health (U.S.)/economics , Research Support as Topic/economics , Research Support as Topic/organization & administration , United States
Global Health/standards , International Agencies/organization & administration , International Health Regulations , Pandemics/prevention & control , Security Measures/legislation & jurisprudence , COVID-19/epidemiology , COVID-19/mortality , Forecasting , Global Health/legislation & jurisprudence , Humans , Information Dissemination , International Cooperation , International Health Regulations/standards , Pandemics/legislation & jurisprudence , Research Support as Topic/organization & administration , Security Measures/standards , World Health Organization/organization & administration
Importance: Emerging vision scientists who have yet to be awarded their first independent funding may have their research careers disproportionately affected by early COVID-19-related disruptions. In September 2020, the Alliance for Eye and Vision Research convened a panel of 22 such scientists (nominated by their academic institutions) to communicate to the US Congress about the importance of vision research. As part of the effort, interviews were conducted with scientists about the effect of the pandemic on their research. Observations: Qualitative areas of adverse consequences from the early months of COVID-19 disruptions included striking interruptions of patient-based research, limits on other types of clinical research, loss of research time for scientists with young children (especially women), challenges with animal colonies and cell cultures, impediments to research collaborations, and loss of training time. Conclusions and Relevance: The early months during the COVID-19 pandemic increased career stress on many early-stage investigators in the vision field and delayed (and may potentially derail) their ability to attract their first independent research funding grant. As a result, federal and private granting agencies may need to take these factors into account to retain talented, early-stage vision researchers.
Biomedical Research/organization & administration , COVID-19/complications , Career Choice , Ophthalmology/organization & administration , Research Personnel/education , SARS-CoV-2 , Stress, Psychological/etiology , Biomedical Research/education , Child, Preschool , Female , Humans , Male , Ophthalmology/education , Quarantine/psychology , Research Personnel/psychology , Research Support as Topic/organization & administration , Stress, Psychological/psychology , Surveys and Questionnaires , United States
Biomedical Research/organization & administration , Cultural Diversity , Academic Success , Clinical Trials as Topic/organization & administration , Editorial Policies , Humans , Minority Groups , National Institutes of Health (U.S.)/organization & administration , Peer Review , Research Support as Topic/organization & administration , Sexism , United States
COVID-19 , Politics , Science/legislation & jurisprudence , Science/organization & administration , Security Measures , COVID-19/epidemiology , CRISPR-Cas Systems , China , Disaster Planning/organization & administration , Humans , International Cooperation , Pandemics/prevention & control , Pandemics/statistics & numerical data , Policy Making , Prejudice/prevention & control , Research Support as Topic/organization & administration , Science/ethics , Science/standards , United States/epidemiology
Budgets/organization & administration , Federal Government , Gift Giving , Goals , Research Support as Topic/economics , Research Support as Topic/organization & administration , Sustainable Development/economics , Humans , Internationality , Research/economics , Research/organization & administration , United Kingdom , United Nations/economics , United Nations/organization & administration
Biomedical Research/economics , Biomedical Research/trends , COVID-19/complications , Goals , National Institutes of Health (U.S.)/economics , Research Support as Topic/economics , Anxiety , Autopsy , Biological Specimen Banks/organization & administration , COVID-19/epidemiology , COVID-19/pathology , COVID-19/physiopathology , COVID-19/therapy , Depression , Disease Susceptibility , Dyspnea , Fatigue , Fever , Humans , Longitudinal Studies , Monitoring, Physiologic , National Institutes of Health (U.S.)/organization & administration , Organ Specificity , Research Support as Topic/organization & administration , Time Factors , United States , Post-Acute COVID-19 Syndrome
Academies and Institutes , Industry , Intersectoral Collaboration , Neoplasms , Public-Private Sector Partnerships , Research Support as Topic , Academies and Institutes/economics , Academies and Institutes/organization & administration , Diffusion of Innovation , Financial Support , Humans , Industry/economics , Industry/organization & administration , Neoplasms/diagnosis , Neoplasms/economics , Neoplasms/therapy , Public-Private Sector Partnerships/economics , Public-Private Sector Partnerships/organization & administration , Research Support as Topic/economics , Research Support as Topic/organization & administration